The 1st International Online Conference on Pathogens
The IOCPa 2027 is now OPEN for abstract submission and registration!
Instruction for authors is now available.
Submit your abstract HERE.
Register to attend HERE.
Explore more Publication Opportunities in Pathogens Special Issue and Medical Sciences Forum Proceedings.
the chair
Advancing Pathogen Research: Unraveling Mechanisms, Strengthening Preparedness, and Advancing Global Health
We are delighted to welcome you to the 1st International Online Conference on Pathogens (IOCPa 2027), hosted by the MDPI journal Pathogens (ISSN 2076-0817, IF 3.8, CiteScore 6.7, indexed in PubMed). This three-day virtual event will take place on 15–17 June 2027 (CEST).
IOCPa 2027 brings together researchers, clinicians, public health professionals, industry experts, and policymakers from around the world to explore the latest advances in pathogen biology, host–pathogen interactions, infectious disease prevention, and therapeutic innovation. As emerging and re-emerging infectious diseases continue to challenge global health, this conference provides a multidisciplinary platform to exchange knowledge, foster collaboration, and accelerate scientific discoveries that improve disease surveillance, prevention, diagnosis, and treatment.
IOCPa 2027 will feature a wide range of sessions covering critical topics, including but not limited to the following:
S1. Viral Pathogens: Replication, Pathogenesis, and Antiviral Strategies;
S2. Bacterial Pathogens: Virulence Mechanisms and Resistance;
S3. Parasitic Pathogens: Host Adaptation and Disease Control;
S4. Fungal Pathogens: Pathogenicity and Emerging Threats;
S5. Immunological Responses to Infection: From Innate Immunity to Immunopathology;
S6. Next-Generation Vaccines and Therapeutics Across Pathogen Kingdoms;
S7. Vector-Borne and Zoonotic Diseases: Ticks and Beyond;
S8. Epidemiology and Outbreak Analytics for Emerging Infectious Diseases.
We warmly invite you to submit your abstracts to IOCPa 2027 and share your latest discoveries, innovative methodologies, and translational research in pathogen and infectious disease science. This conference offers a unique opportunity to engage with an international community of experts, exchange ideas across disciplines, and contribute to advancing our understanding of pathogens and improving global preparedness against infectious diseases. Together, let us drive innovation and collaboration toward a healthier and more resilient future.
Sincerely,
Conference Chair
Prof. Dr. Moriya Tsuji
School of Engineering Medicine, Texas A&M University, USA
Meet Our Chair
School of Engineering Medicine, Texas A&M University, Houston, USA;Prof. Dr. Moriya Tsuji was a Professor of Medicine in the Division of Infectious Diseases, Department of Medicine, at Columbia University Irving Medical Center. He also held a professorship at the Aaron Diamond AIDS Research Center prior to his move in March 2026 to the School of Engineering Medicine at Texas A&M University in Houston, Texas, USA. Prof. Dr. Tsuji received his MD degree in 1983 from The Jikei University School of Medicine in Tokyo, Japan, and his PhD in immunology in 1987 from the Faculty of Medicine at the University of Tokyo. He is widely recognized as a leader in the development of humanized mouse models that recapitulate the human immune system, as well as an expert in T cell–mediated immunity against infectious diseases and cancer, and in the development of glycolipid-based vaccine adjuvants. Prof. Dr. Tsuji has authored over 160 peer-reviewed publications in leading journals, including Nature, Nature Medicine, The Journal of Experimental Medicine, The Journal of Clinical Investigation, and Proceedings of the National Academy of Sciences of the United States of America. In 2021, he was elected as a Fellow of the American Society of Tropical Medicine and Hygiene (FASTMH). He has served on several prominent advisory bodies, including the Vaccine Science Portfolio Advisory Council (VSPAC) of the PATH Malaria Vaccine Initiative (2008–2012) and the Malaria Vaccine Consultation Group (MVCG) of NIAID/NIH (2010–2012). In addition, he served as a founding roster member of the Immunity and Host Defense (IHD) study section at NIAID/NIH from 2003 to 2008. Since 2015, he has been an International Advisory Member of the International Immunological Memory and Vaccine Forum (IIMVF).
Important Dates
- Abstract submission deadlineFeb 17, 2027
- Abstract acceptance notificationMar 17, 2027
- Registration end dateJun 10, 2027
- Registration DeadlineJun 10, 2027
